Much of the media coverage echoed the same reassuring message: drink up, your heart and liver will thank you.
Coffee at that level was linked to lower risk of heart disease, stroke, heart failure, type 2 diabetes, and some irregular heart rhythms.
Against people who drank none, those reporting five or more cups a day had a 32% lower risk of cirrhosis, a 47% lower risk of liver cancer and a 42% lower risk of dying of liver disease.
“We would not recommend that someone begin drinking coffee solely for liver protection based on this study alone,” Yang said.
“Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank.” Clinical Gastroenterology and Hepatology, July 1, 2026.
Pour a second cup. Pour a third. Somewhere around the fourth, the health advice you’ve been given over the years starts arguing with itself.
This month made that feeling worse, not better. Two major coffee studies landed within weeks of each other.
Much of the media coverage echoed the same reassuring message: drink up, your heart and liver will thank you.
Both papers also contain a more complicated story – the part that could actually change what ends up in your mug.
Five cups and a caveat
On July 20, the American Heart Association published a scientific statement titled “Caffeine and Cardiovascular Disease” in its peer-reviewed journal Circulation.
A volunteer writing group chaired by Gregory M. Marcus, a professor of medicine at the University of California, San Francisco School of Medicine (USC Medical School), reviewed the existing evidence rather than running a new experiment.
The analysis suggested that for most adults, up to 400 milligrams of caffeine a day – or about five 8-ounce (237-milliliter) cups of plain black coffee – appears safe.
Coffee at that level was linked to lower risk of heart disease, stroke, heart failure, type 2 diabetes, and some irregular heart rhythms.
The line between benefit and caution
Further down the same document comes a different message: drinking more than four cups a day may raise the risk of heart failure.
The line between benefit and caution is just one cup.
Something else the coverage often skipped: a scientific statement is not a guideline.
In fact, the association left caffeine out of its 2026 dietary guidance altogether, concluding that the evidence was not strong enough to support a recommendation.
Blood pressure breaks the pattern
Here is the part that should make you pause.
Among people whose blood pressure currently sits in the optimal range, one to three cups a day was associated with a slightly higher chance of developing high blood pressure.
More than three cups was associated with a lower chance.
More coffee, less risk. Less coffee, more risk. That is not the pattern scientists usually expect, where increasing the dose generally strengthens the effect.
The statement does not fully explain the pattern. It notes that regular coffee drinkers may develop tolerance, offering one possible explanation.
Group membership may matter too. The light-drinker column can quietly collect people who cut back for a medical reason, while heavy drinkers may be the ones whose bodies handle caffeine easily in the first place.
No randomized trial has yet settled the question.
Energy shots are not coffee
A brewed cup of regular coffee carries roughly 9.4 to 20.6 milligrams of caffeine per fluid ounce (30 milliliters).
An energy shot can pack 40 to 69 milligrams into that same ounce – three to four times denser.
At those concentrations the pattern flips. Higher caffeine intake of the kind found in energy drinks and shots was associated with cardiovascular harm, including greater risk of high blood pressure and irregular heart rhythm.
Very high doses have been linked to abnormal rhythms even in people you would assume were safe, such as healthy adults under 30.
“However, high doses of caffeine, such as those found in energy drinks including energy shots, may have harmful effects on the heart and should be avoided,” said Marcus.
The authors also addressed an easy assumption to make. Findings for coffee cannot simply be extended to energy drinks, which often contain additional ingredients that may increase the rate of caffeine absorption.
Liver scans show less scarring
The second finding came out of Cedars-Sinai on July 1, in Clinical Gastroenterology and Hepatology.
Hepatologist Hyun-Seok Kim and colleagues tracked 354,957 adults in the UK Biobank who had neither cirrhosis nor liver cancer at the start, for a median of 13 years.
Against people who drank none, those reporting five or more cups a day had a 32% lower risk of cirrhosis, a 47% lower risk of liver cancer and a 42% lower risk of dying of liver disease.
Benefits showed up at one to two cups and looked strongest around three to four.
The scans agreed with the paperwork. Heavier drinkers tended to show less liver fat, less iron, less fibrosis (the scarring that stiffens the organ) and less inflammation on MRI.
Blood proteins linked to scarring were measured at lower levels too.
This was observational research. It can show that coffee habits and healthier livers occur together, but it cannot show that one causes the other.
The UK Biobank also includes volunteers who tend to be older and healthier than the general population.
Decaf worked just as well
Now the twist that quietly dismantles the caffeine story: the liver results looked about the same in decaf drinkers.
If caffeine were doing the work, decaf should have come up short.
Study senior author Ju Dong Yang, medical director of the Liver Cancer Program at Cedars-Sinai, drew a firm line around what the study permits.
“We would not recommend that someone begin drinking coffee solely for liver protection based on this study alone,” Yang said.
“Prevention should continue to focus on maintaining a healthy weight, limiting alcohol, exercising regularly, and managing blood sugar, blood pressure, and cholesterol.”
The heart statement hits the same wall from the other direction, noting how hard it is to separate caffeine from everything else in the cup.
For example, cafestol is found in unfiltered coffee like espresso, French press, and boiled coffee. Randomized trials associated this compound with higher LDL, the “bad” cholesterol.
Why does coffee advice keep changing?
Coffee advice keeps changing because hardly any of it comes from experiments.
“Studies of caffeine, one of the most commonly consumed drugs in the world, are largely observational, meaning that confounding by other factors remains an important consideration in interpreting the majority of scientific results,” the AHA writing group stated.
The experts added that more randomized controlled trials are needed.
In plain terms, coffee drinkers and non-drinkers differ in countless other ways, and any one of those differences could be driving the result.
Differences in income, sleep, smoking habits, or even whether a doctor advised someone to cut back on coffee because of an existing health problem could all influence the outcome.
Even the randomized data split. Caffeine in coffee came out associated with lower atrial fibrillation risk but a higher rate of premature ventricular contractions – the early extra beats from the heart’s lower chambers.
“People can respond very differently to caffeine based on various factors, such as age, medications, underlying health conditions, genetics and how quickly their bodies metabolize it,” said Marcus.
Caffeine labels hit the FDA agenda
Three weeks before the heart statement, on June 29, the FDA added a document called “Labeling Caffeine Content in Foods and Beverages; Draft Guidance for Industry” to its 2026 guidance agenda.
Nothing has changed. Guidance is not law, no draft language exists, and no deadlines are set.
A company still has to list caffeine as an ingredient only when it is added on its own, and never has to tell you the milligrams in the can.
Both papers keep circling the same gap. An ordinary cup of coffee, loosely defined but heavily studied, gets a green light.
Concentrated products, often higher in caffeine and less consistently labeled, get a warning. The label that would clearly separate the two still does not exist.
—–
Marcus GM, Hu FB, van Dam RM, Cornelis MC, Dewland TA, Kang J, Larsson SC, Page RL II, Parekh N. “Caffeine and Cardiovascular Disease: A Scientific Statement From the American Heart Association.” Circulation, July 20, 2026.
Kim H-S, Rezaee-Zavareh MS, Wang Y, Lu SC, Pandol S, Yang JD. “Coffee Consumption and Improved Liver Outcomes: Clinical, Imaging, and Proteomic Evidence From the UK Biobank.” Clinical Gastroenterology and Hepatology, July 1, 2026.
—–
Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates.
Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
—–
